Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-30,254
Closed -$237K 116
2024
Q4
$237K Sell
30,254
-2,806
-8% -$23.1K 0.04% 112
2024
Q3
$245K Sell
33,060
-590
-2% -$4.96K 0.05% 99
2024
Q2
$270K Hold
33,650
0.05% 98
2024
Q1
$392K Sell
33,650
-1,650
-5% -$18.3K 0.08% 88
2023
Q4
$394K Sell
35,300
-20,200
-36% -$186K 0.09% 82
2023
Q3
$857K Buy
55,500
+25,500
+85% +$428K 0.2% 64
2023
Q2
$569K Buy
30,000
+11,650
+63% +$205K 0.13% 70
2023
Q1
$279K Buy
18,350
+17,350
+1,735% +$226K 0.07% 87
2022
Q4
$12.7K Sell
1,000
-1,500
-60% -$13.5K ﹤0.01% 228
2022
Q3
$14K Sell
2,500
-29,450
-92% -$129K ﹤0.01% 195
2022
Q2
$103K Buy
31,950
+1,000
+3% +$3.02K 0.03% 113
2022
Q1
$117K Buy
30,950
+10,600
+52% +$68.3K 0.03% 116
2021
Q4
$266K Sell
20,350
-1,700
-8% -$26.9K 0.05% 99
2021
Q3
$432K Hold
22,050
0.09% 81
2021
Q2
$412K Buy
22,050
+3,850
+21% +$85.9K 0.09% 89
2021
Q1
$431K Buy
18,200
+10,300
+130% +$238K 0.1% 90
2020
Q4
$193K Buy
7,900
+3,400
+76% +$86.9K 0.05% 100
2020
Q3
$115K Buy
+4,500
New +$143K 0.03% 105

Other funds holding ETNB

Bourgeon Capital Management's ETNB Position: Q1 2025 in Review

Bourgeon Capital Management sold out of 89bio (ETNB) in Q1 2025, closing a stake of 30,254 shares — an estimated $237K sold.

Bourgeon Capital Management first reported a position in ETNB in Q3 2020 and held it in 18 quarters. The position peaked at $857K in Q3 2023. 186 funds tracked by Wall St. Rank hold ETNB as of Q1 2025.

  • Bourgeon Capital Management reported no remaining 89bio position as of Q1 2025 after selling out during the quarter.
  • Bourgeon Capital Management sold 30,254 89bio shares in Q1 2025, an estimated $237K.
  • Bourgeon Capital Management first reported a position in 89bio in Q3 2020 and held it in 18 quarters.
  • Bourgeon Capital Management's 89bio position peaked at $857K in Q3 2023.
  • 186 funds tracked by Wall St. Rank held 89bio as of Q1 2025.

Based on Bourgeon Capital Management's 13F filing for Q1 2025, filed 9 Apr 2025.